Stay updated on Atezolizumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Atezolizumab in Advanced NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice was added to the page. The site revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary is now displayed; QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Capitalization for 'No FEAR Act Data' has been standardized.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed as part of the site's versioning metadata on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a Locations section listing Orlando, FL and Pittsburgh, PA, replacing the previous Florida Locations and Pennsylvania Locations blocks, and shows a new Revision: v3.3.3.SummaryDifference0.3%

- Check91 days agoChange DetectedRevision: v3.3.2 from v3.2.0; no study details are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.